安旭生物 (688075.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(安旭生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 155,111,696.94118,750,019.34129,406,701.97187,216,726.29111,765,659.3982,897,153.77121,477,537.33
 营业收入(元) 155,111,696.94118,750,019.34129,406,701.97187,216,726.29111,765,659.3982,897,153.77121,477,537.33
二、营业总成本(元) 156,802,363.30120,439,537.94112,894,368.80226,947,165.80116,997,640.04-16,650,313.16115,414,863.11
 营业成本(元) 86,597,656.9471,942,240.7574,913,346.43131,912,352.9561,417,103.6738,192,541.9958,923,150.14
 研发费用(元) 27,424,786.3229,833,510.5019,840,217.3937,266,220.3119,670,180.5324,566,995.7023,771,592.09
 营业税金及附加(元) 1,724,860.24239,630.541,996,951.093,420,002.311,153,461.731,150,948.382,835,445.82
 销售费用(元) 11,266,877.0014,170,309.018,524,969.7711,171,700.5111,636,860.4911,406,553.218,619,306.77
 管理费用(元) 12,742,854.8611,432,913.2410,862,380.1023,054,724.5314,617,285.3817,607,528.2311,252,579.40
 财务费用(元) 17,045,327.94-7,179,066.10-3,243,495.9820,122,165.198,502,748.23-109,574,880.6710,012,788.90
  其中:利息收入(元) -----23,462,957.97--
 资产减值损失(元) --1,547,594.72230,121.79-26,566,751.91---
 信用减值损失(元) ----109,725.52-2,600,595.25--
三、其他经营收益
 加:公允价值变动收益(元) 9,005,532.3010,292,103.726,095,879.37-23,642,622.63-14,859,423.22-13,219,095.74-3,080,551.38
 加:投资收益(元) 12,754,169.0036,133,650.2138,691,313.6522,546,188.0839,134,295.8835,487,690.0642,938,603.12
 资产处置收益(元) -112,013.814,800,084.91-175,791.22989,795.56-3,863.706,528,332.38-352,217.59
 其他收益(元) 66,587.871,355,368.0913,159,386.7922,873,224.234,388,265.00342,937.9010,457,547.10
四、营业利润(元) 20,023,608.9949,468,837.4074,513,243.55-43,640,331.7023,427,293.30131,671,344.5656,026,055.47
 加:营业外收入(元) 47,923.6832,875.2449,952.16-513,524.5667,168.78602,662.978,860.98
 减:营业外支出(元) 30,855.9398,784.47237.7218,631,008.385,086,498.56111,492.083,571.97
五、利润总额(元) 20,040,676.7549,402,928.1674,562,957.99-62,784,864.6418,407,963.52132,162,515.4556,031,344.48
 减:所得税费用(元) -239,279.384,269,313.774,228,237.87-17,386,760.03-1,453,518.6016,039,468.145,652,959.89
六、净利润(元) 20,279,956.1345,133,614.3970,334,720.12-45,398,104.6119,861,482.12116,123,047.3150,378,384.59
(一)按经营持续性分类
  持续经营净利润(元) 20,279,956.1345,133,614.3970,334,720.12-45,398,104.6119,861,482.12116,123,047.3150,378,384.59
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 20,464,686.1245,128,212.8570,190,798.47-45,286,092.7020,064,621.75115,943,591.5750,831,559.77
  少数股东损益(元) -184,729.995,401.54143,921.65-112,011.91-203,139.63179,455.74-453,175.18
 扣除非经常性损益后的净利润(元) 493,907.84-744,692.6519,629,646.53-46,781,036.9710,954.2490,755,992.218,359,409.24
七、每股收益
 一、基本每股收益(元) 0.160.360.55-0.360.160.750.56
 二、稀释每股收益(元) 0.160.360.55-0.360.160.750.56
八、其他综合收益(元) 6,714,712.63888,610.3635,730.24-862,956.84-3,135.53-7,648,485.258,357,524.90
 归属于母公司股东的其他综合收益(元) 6,714,712.63888,610.3635,730.24-862,956.84-3,135.53-7,648,485.258,357,524.90
九、综合收益总额(元) 26,994,668.7746,022,224.7570,370,450.36-46,261,061.4519,858,346.58108,474,562.0758,735,909.49
 归属于母公司所有者的综合收益总额(元) 27,179,398.7646,016,823.2170,226,528.71-46,149,049.5420,061,486.21108,295,106.3359,189,084.67
 归属于少数股东的综合收益总额(元) -184,729.995,401.54143,921.65-112,011.91-203,139.63179,455.74-453,175.18
公告日期 2024-10-312024-08-302024-04-302024-04-302023-10-312023-08-312023-04-29
审计意见(境内) 标准无保留意见

前瞻产业研究院